Bath & Body Works, Inc.
NYSE:BBWISpecialty Retail
+$0.25 today
- Market cap
- $3.76B
- Beta
- 1.39
- P/E (TTM)
- 5.8
- EPS (TTM)
- $3.60
- Dividend yield
- 3.86%
Volume 9.61M
Average 6.12M
BBWI Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Bath & Body Works, Inc.NYSE: BBWI
Cost of Revenue · Q2 FY2026 · quarter ended Aug 2026
Cost of revenue declines year over year
Q2 FY2026 cost of revenue of $822M fell 9.6% year over year, behind the -1.3% change in trailing-twelve-month cost of revenue. Sequentially, it rose 3.9% from the prior quarter. Over 3 fiscal years it compounded at -1.6% a year.
Context
- Cost of revenue amounted to 56.3% of revenue in FY2025, up 0.5 pp from a year earlier.
- Cost of revenue increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -9.6% toward the trailing-twelve-month pace of -1.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 4.1B USD
- Year-over-year change
- +0.7%
- 4-year CAGR
- +0.5%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-31 | 4.1B | +0.7% |
| FY2024 | 2025-02-01 | 4.07B | -2.9% |
| FY2023 | 2024-02-03 | 4.19B | -2.6% |
| FY2022 | 2023-01-28 | 4.31B | +6.9% |
| FY2021 | 2022-01-29 | 4.03B | — |
Cost of Revenue vs competitors
How BBWI compares with its peers on the latest reported figures
- BBWI's LTM Aug 2026 cost of revenue of $4.03B is the 6th highest of the 11 companies compared; the peer median is $3.44B.
- Its year-over-year change of -1.3% is the 7th highest of 11, against a peer median of +3.3%.
- Cost of revenue amounts to 55.9% of revenue for BBWI, versus a peer median of 75.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $18.33B | -3.5% | +12.9% | 84.2% | |
| LTM Aug 2026 | $14.57B | +7.5% | -2.2% | 64.0% | |
| LTM Mar 2026 | $5.9B | -6.3% | +0.8% | 77.6% | |
| LTM Sep 2026 | $4.23B | -10.7% | +1.5% | 81.4% | |
| LTM Jul 2026 | $4.05B | +7.8% | +5.4% | 62.5% | |
| LTM Aug 2026 | $4.03B | -1.3% | -1.6% | 55.9% | |
| LTM Jun 2026 | $2.84B | +3.0% | -2.6% | 74.9% | |
| LTM Mar 2026 | $2.74B | +53.1% | +16.6% | 195.6% | |
| LTM Sep 2026 | $1.71B | +5.9% | +8.4% | 65.2% | |
| LTM Mar 2026 | $797.48M | -19.4% | — | 75.2% | |
| LTM Jun 2026 | $792.14M | +3.6% | +3.2% | 27.7% | |
| Peer median (excluding BBWI) | $3.44B | +3.3% | +3.2% | 75.0% | |
Competitors are the stored peer set for BBWI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Jan 2022 | FY2022 Jan 2023 | FY2023 Feb 2024 | FY2024 Feb 2025 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 7.88B | 7.56B | 7.43B | 7.31B | 7.29B |
| Cost of Revenue | 4.03B | 4.31B | 4.19B | 4.07B | 4.1B |
| Gross Profit | 3.86B | 3.26B | 3.24B | 3.23B | 3.19B |
| Gross Margin | 48.9% | 43.1% | 43.6% | 44.3% | 43.7% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.85B | 1.88B | 1.95B | 1.97B | 2.06B |
| Operating Expenses | 1.85B | 1.88B | 1.95B | 1.97B | 2.06B |
| Depreciation & Amortization | 363M | 221M | 269M | 282M | 254M |
| EBITDA | 2.17B | 1.61B | 1.64B | 1.62B | 1.41B |
| EBITDA Margin | 27.6% | 21.3% | 22.0% | 22.2% | 19.4% |
| Operating Income | 2.01B | 1.38B | 1.29B | 1.27B | 1.13B |
| Operating Margin | 25.5% | 18.2% | 17.3% | 17.3% | 15.4% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 388M | 348M | 345M | 312M | 276M |
| Other Income / Expenses | (586M) | (331M) | (264M) | (238M) | (244M) |
| Income Before Tax | 1.42B | 1.05B | 1.02B | 1.03B | 882M |
| Pre-Tax Margin | 18.1% | 13.8% | 13.7% | 14.1% | 12.1% |
| Income Tax Expense | 348M | 251M | 143M | 230M | 233M |
| Net Income | 1.33B | 800M | 878M | 798M | 649M |
| Net Margin | 16.9% | 10.6% | 11.8% | 10.9% | 8.9% |
| EPS (Basic) | 4.96 | 3.45 | 3.89 | 3.62 | 3.07 |
| EPS (Diluted) | 4.88 | 3.43 | 3.83 | 3.61 | 3.07 |
| Weighted Avg Shares | 269M | 232M | 225.94M | 220M | 211.61M |
| Weighted Avg Shares (Diluted) | 273M | 233M | 229M | 221M | 211.61M |
Bath & Body Works, Inc.
NYSE:BBWI
Intrinsic Alpha fair value
Locked
Current Price
$18.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.